Explore By Subject Area   

Immuno-Oncology 360°

Date: Mar 24, 2025 - Mar 26, 2025

Location: Boston, MA


"I very much enjoyed the presentations from financial institutions and others addressing global market trends, as I don't typically hear that perspective in other conferences."

- Vanessa Ott, Promega

"Fantastic opportunity to learn, connect the dots, meet people and have both science and business discussions."

- Gregory Frank, GE HealthCare

image placeholder

"I enjoyed the blend of science, business and representation from pharma, biotech, and platforms"

​​​​​​​-Matt Silver, Takeda

"It was an exhilarating event, uniting experts from the biotech industry, finance sector, and pharmaceutical companies. All united by the passion of advancing Immuno-oncology-based therapies and curiosity for the future directions of the IO field, making it a notable occasion for collaboration and knowledge exchange."

- Biond Biologics

image placeholder

"IO360 was such a great opportunity to see good friends, learn of new and merging data, and get fresh perspectives from a full spectrum of stakeholders that give it the name."

- Dr James Gulley, National Cancer Institute

"Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"
- Dr Gilson Baia,  Champions Oncology

"IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"

​​​​​​​- Jim Mansfield, PerkinElmer

image placeholder

"Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."

​​​​​​​- Dr Christine Ward, BMS 

"Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an ​​​​​​impressive speaking faculty."

- Eileen Daniels, Nektar Therapeutics

"The conference was informative on many fronts; not just scientific progress but also with Big Pharma vs small bio perspective and the investment community. I really enjoyed the Women's Luncheon to hear different perspectives from women leaders in our field."

- Laura Agensky, CUE Biopharma

image placeholder

"The breadth and depth of this IO dedicated meeting is just unmatched, and it becomes better year after year. Kudos."

-Dr Samuel Zhang, Gracell Biotechnologies

"Excellent speakers, diverse topics and good perspectives."

- Scott Turner, Pliant Therapeutics

"Your team did a wonderful job in putting together an interesting and relevant program."

- Lew Bender, Intensity Therapeutics

image placeholder

"I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."

- Jacqueline Karmel, Roche

"Nice mixture of large pharma and smaller drug discovery companies."

- Spencer Eggen, Bruker

2024 Sponsors

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.